These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10625946)

  • 21. Role of phytate and osteopontin in the mechanism of soft tissue calcification.
    Grases F; Prieto RM; Sanchis P; Saus C; De Francisco T
    J Nephrol; 2008; 21(5):768-75. PubMed ID: 18949733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypolipidemic action of phytic acid (IP6): prevention of fatty liver.
    Katayama T
    Anticancer Res; 1999; 19(5A):3695-8. PubMed ID: 10625942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxalate and phytate of soy foods.
    Al-Wahsh IA; Horner HT; Palmer RG; Reddy MB; Massey LK
    J Agric Food Chem; 2005 Jul; 53(14):5670-4. PubMed ID: 15998131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
    Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
    Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma.
    Rizvi I; Riggs DR; Jackson BJ; Ng A; Cunningham C; McFadden DW
    J Surg Res; 2006 Jun; 133(1):3-6. PubMed ID: 16563438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HIV-1 activity of myo-inositol hexaphosphoric acid (IP6) and myo-inositol hexasulfate(IS6).
    Otake T; Mori H; Morimoto M; Miyano K; Ueba N; Oishi I; Kunita N; Kurimura T
    Anticancer Res; 1999; 19(5A):3723-6. PubMed ID: 10625947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytate prevents tissue calcifications in female rats.
    Grases F; Prieto RM; Simonet BM; March JG
    Biofactors; 2000; 11(3):171-7. PubMed ID: 10875304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protein inhibitors of crystallization. Their characterization and potential role in calcium lithiasis].
    Montalto G; Multigner L; Sarles H; De Caro A
    Nephrologie; 1984; 5(4):155-7. PubMed ID: 6527717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis.
    Schlemmer U; Frølich W; Prieto RM; Grases F
    Mol Nutr Food Res; 2009 Sep; 53 Suppl 2():S330-75. PubMed ID: 19774556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.
    Fakier S; Rodgers A; Jackson G
    Urolithiasis; 2019 Dec; 47(6):493-502. PubMed ID: 30767040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y
    Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.
    Singh RP; Agarwal R
    Anticancer Res; 2005; 25(4):2891-903. PubMed ID: 16080543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does a medical treatment for calcic renal lithiasis exist?
    Nouv Presse Med; 1976 Jan; 5(3):139-45. PubMed ID: 1264655
    [No Abstract]   [Full Text] [Related]  

  • 35. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
    Tantivejkul K; Vucenik I; Shamsuddin AM
    Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer.
    Somasundar P; Riggs DR; Jackson BJ; Cunningham C; Vona-Davis L; McFadden DW
    J Surg Res; 2005 Jun; 126(2):199-203. PubMed ID: 15919420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: a pilot study in Sprague-Dawley rats.
    Grases F; Sanchis P; Perelló J; Isern B; Prieto RM; Fernández-Palomeque C; Torres JJ
    Circ J; 2007 Jul; 71(7):1152-6. PubMed ID: 17587727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary inositol hexakisphosphate, but not myo-inositol, clearly improves hypercholesterolemia in rats fed casein-type amino acid mixtures and 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane.
    Okazaki Y; Katayama T
    Nutr Res; 2008 Oct; 28(10):714-21. PubMed ID: 19083479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer Properties of Inositol Hexaphosphate and Inositol: An Overview.
    Vucenik I
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S18-S22. PubMed ID: 31619624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.